COVID-19 drug remdesivir recommended for EU approval

The EMA’s human medicines committee (CHMP) has recommended granting a conditional marketing authorisation to Gilead’s COVID-19 treatment remdesivir – making it the first drug of its kind to be g

Gilead files remdesivir for EU approval, with a verdict poss...

The EMA has said it will fast-track the review of Gilead Sciences’ remdesivir as a treatment for COVID-19, after the US biopharma submitted its marketing application for the dr

EU regulators warn over safety of Trump's favourite COVID dr...

As the search for therapies for COVID-19 continues, European regulators have urged caution over the cardiac side-effects of chloroquine and its close relative hydroxychloroquine.

EMA won't clear chloroquine for COVID-19 without trial data

The European drugs regulator has stopped short of granting widespread use of the drug chloroquine against COVID-19, days after the FDA said it could be used under emergency measures to figh

CHMP backs safety of anticoagulants after real-world study

Novartis closes on EU approval for SMA gene therapy Zolgensm...